Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Insider trades › Bio-Techne › CEO received an award of 58K TECH derivative securities Insider trades
Why it stands out Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Transaction date Aug 17, 2026
Reporting period Not applicable
Filed with the SEC Aug 19, 2026 CEO Grant / award
Context Classification grant award
Code A — grant or award
Planned / mechanical clue Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID 0000914190-26-000133
Filed / recorded
Aug 19, 2026, 8:48 PM UTC
Added to OQRO Oct 2, 2026, 12:27 PM UTC
Data quality Verified: identifiers matched exactly
Reporting person Kim Kelderman
Relationship Director, Officer
Officer title Chief Executive Officer
Security Restricted Stock Units
Table Derivative (Table II)
Transaction date Aug 17, 2026
Acquired / disposed Acquired (A)
Footnotes from the filing Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 19,197 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 19,196 restricted stock units vest on 8/17/2029.
Around the same time Insider filing
Traded Aug 17 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Aug 17 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Aug 17 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
The company's last weighty Form 8-K report up to this date: reported its results, 5 days earlier (Aug 12, 2026).
Jun 23, 2026 Company filing · Form 8-K · Material agreement, Executive change Changed a top executive or board member, and signed an important agreement “On June 23, 2026, in connection with the contemplated Merger, the Compensation Committee of the Board (the “ Compensation Committee ”) approved cash retention bonus awards to each of the Company’s current named executive officers pursuant to retention agreements (the “ Retention Agreements ”) in order to encourage the Company’s named executive officers to remain with the Company and motivate their continued strong…” Aug 6, 2026 5% stake FMR LLC reported a passive stake (13G) of 8.1% Aug 12, 2026 Company filing · Form 8-K · Results, Other news Reported its results, and reported other company news What came next Nov 5, 2026 5% stake FMR LLC reported a passive stake (13G) of 0.7%